Graft-versus-host disease

Graft-versus-host disease

Graft-versus-host disease

On this page

Pathophysiology - Donor's Deadly Attack

  • Mechanism: Immunocompetent donor T-cells from the graft recognize the recipient's tissues as foreign, as the host is too immunocompromised to reject the graft.
  • Key Players: Donor CD4+ and CD8+ T-cells react to the host's disparate Major Histocompatibility Complex (MHC) antigens.
  • Cascade: This triggers a massive inflammatory response, often called a "cytokine storm," leading to widespread tissue damage.

GVHD: Canonical and alternative mechanisms

Graft-versus-Leukemia (GVL) Effect: A beneficial "side effect" where donor T-cells also eliminate residual host cancer cells, particularly in hematopoietic stem cell transplants for leukemia.

  • Mnemonic (📌): Major targets are Skin, Liver, GI tract ("Some Lethal Grafts").

Clinical Presentation - Acute vs. Chronic Clash

FeatureAcute GVHDChronic GVHD
OnsetTypically < 100 days post-transplantTypically > 100 days post-transplant
MechanismDonor CD8+ T-cells attack host epithelial cellsDonor CD4+ T-cells & B-cells cause autoimmune, fibrotic process
SkinMaculopapular rash, erythema, bullae (may resemble SJS/TEN)Poikiloderma, scleroderma-like changes, lichen planus-like lesions
GI TractProfuse, watery/bloody diarrhea; nausea, vomiting; abdominal painEsophageal webs/strictures, malabsorption, weight loss
LiverJaundice, ↑ conjugated bilirubin & alkaline phosphataseCholestatic jaundice, potentially progressing to cirrhosis
Other-Sicca syndrome (dry eyes/mouth), bronchiolitis obliterans, myositis

⭐ Chronic GVHD is a major cause of late, non-relapse mortality following allogeneic transplant. It can arise de novo without any preceding acute GVHD.

Diagnosis & Prevention - Taming the Treachery

  • Diagnosis: Primarily clinical (maculopapular rash, diarrhea, ↑LFTs).
    • Biopsy is definitive: Shows lymphocytic infiltrate & apoptosis in skin, gut, or liver.
  • Prevention: The cornerstone of management.
    • HLA matching of donor and recipient is paramount.
    • Immunosuppressive prophylaxis is standard.
      • Calcineurin inhibitors (Cyclosporine, Tacrolimus)
      • Methotrexate

⭐ Biopsy of affected organs (skin, gut, liver) is the gold standard for diagnosis, revealing lymphocytic infiltration and apoptosis, which confirms the T-cell mediated assault.

High‑Yield Points - ⚡ Biggest Takeaways

  • In GVHD, transplanted donor T-cells attack recipient tissues, primarily after allogeneic bone marrow transplants.
  • Key targets are the skin (diffuse maculopapular rash), liver (jaundice, ↑ LFTs), and GI tract (profuse diarrhea).
  • The mechanism involves donor T-cells recognizing host MHC antigens as foreign.
  • Acute GVHD develops <100 days post-transplant; chronic GVHD develops >100 days.
  • Prophylaxis and treatment rely on immunosuppressive drugs like corticosteroids and cyclosporine.
  • A beneficial graft-versus-leukemia effect may also occur in cancer patients.

Practice Questions: Graft-versus-host disease

Test your understanding with these related questions

A 40-year-old male with a history of chronic alcoholism recently received a liver transplant. Two weeks following the transplant, the patient presents with a skin rash and frequent episodes of bloody diarrhea. A colonoscopy is performed and biopsy reveals apoptosis of colonic epithelial cells. What is most likely mediating these symptoms?

1 of 5

Flashcards: Graft-versus-host disease

1/6

CML may transform to acute _____ leukemia (2/3rd of cases)

TAP TO REVEAL ANSWER

CML may transform to acute _____ leukemia (2/3rd of cases)

myeloid

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial